<span style="display: block; margin-top: 60px;">Time to Think<span style="font-size: 0.6em; display: block; margin: 5px 0;">Time-in-Range</span></span>

Time in Range Guide

To find out more about Time-In-Range and the impact it can have on your patients, download the guide below.

Time in Range Guide

Comparing the two second generation basal insulins in T1DM


Did you know that InRange* is the first randomised control trial to use Time-In-Range as the primary endpoint? The study compares the second generation basal insulin analogues Toujeo and insulin degludec 100U/mL in people with T1DM. Find out more in the InRange study below.

InRange Study Design

*The In-Range study has been sponsored by Sanofi

Lady talking on phone

Always up to date?

Webinars, evidence, expert videos, peer-to-peer events… Do you want to be the first to know when new, relevant information is available? Let us know and we’ll send you a message. 

This site uses cookies to store information on your computer. Some cookies on this site are needed because the site won’t work as expected without them. To learn more about cookies, please read our Cookie Policy.
By closing this message or using the website, you agree to our use of cookies on this device in agreement with our Cookie Policy, unless you have turned them off.
Accept and close